Literature DB >> 18547363

Ochratoxin A impairs Nrf2-dependent gene expression in porcine kidney tubulus cells.

C Boesch-Saadatmandi1, A E Wagner, A C Graeser, C Hundhausen, S Wolffram, G Rimbach.   

Abstract

The mycotoxin, ochratoxin A (OTA), which is produced by Aspergillus and Penicillium subspecies, is frequently present in feedstuffs. Ochratoxin A exhibits a wide range of toxic activities including nephrotoxicity. However, the underlying molecular mechanisms of OTA-induced cellular nephrotoxicity have yet not been fully elucidated. Nrf2 is a basic leucine zipper transcriptional activator essential for the coordinated transcriptional induction of antioxidant and xenobiotic metabolizing enzymes in the kidney. Therefore, in the present study, the effects of OTA on the nuclear translocation and transactivation of the transcription factor Nrf2 as well as mRNA levels of Nrf2 target genes including glutathione-S-transferase and gamma-glutamylcysteinyl synthetase have been studied in cultured porcine kidney tubulus cells (LLC-PK1). Nrf2 was induced by sulforaphane, a well-known activator of this transcription factor. Ochratoxin A significantly decreased gamma-glutamylcysteinyl synthetase and glutathione-S-transferase mRNA levels in LLC-PK1 cells. Decreased mRNA levels of gamma-glutamylcysteinyl synthetase and glutathione-S-transferase were accompanied by a lowered nuclear translocation and transactivation of Nrf2. Furthermore, OTA also lowered Nrf2 mRNA levels. Current data indicate that OTA nephrotoxicity may be, at least partly, mediated by an Nrf2-dependent signal transduction pathway.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18547363     DOI: 10.1111/j.1439-0396.2008.00838.x

Source DB:  PubMed          Journal:  J Anim Physiol Anim Nutr (Berl)        ISSN: 0931-2439            Impact factor:   2.130


  21 in total

Review 1.  Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents.

Authors:  Sadagopan Magesh; Yu Chen; Longqin Hu
Journal:  Med Res Rev       Date:  2012-05-01       Impact factor: 12.944

2.  Transcriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity.

Authors:  Lauren M Aleksunes; Michael J Goedken; Cheryl E Rockwell; Juergen Thomale; Jose E Manautou; Curtis D Klaassen
Journal:  J Pharmacol Exp Ther       Date:  2010-07-06       Impact factor: 4.030

3.  Aspergillus awamori attenuates ochratoxin A-induced renal and cardiac injuries in rabbits by activating the Nrf2/HO-1 signaling pathway and downregulating IL1β, TNFα, and iNOS gene expressions.

Authors:  Doaa H Assar; Samah Abou Asa; Moshira A El-Abasy; Zizy I Elbialy; Mustafa Shukry; Amera Abd El Latif; Mona N BinMowyna; Norah A Althobaiti; Mohammed A El-Magd
Journal:  Environ Sci Pollut Res Int       Date:  2022-05-16       Impact factor: 5.190

4.  A comparison between the effects of ochratoxin A and aristolochic acid on the inflammation and oxidative stress in the liver and kidney of weanling piglets.

Authors:  D E Marin; G C Pistol; M Gras; M Palade; I Taranu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-07-22       Impact factor: 3.000

5.  Ochratoxin A induces apoptosis in neuronal cells.

Authors:  Xiangnan Zhang; Christine Boesch-Saadatmandi; Yijia Lou; Siegfried Wolffram; Patricia Huebbe; Gerald Rimbach
Journal:  Genes Nutr       Date:  2009-01-16       Impact factor: 5.523

6.  Evidence for a role of oxidative stress in the carcinogenicity of ochratoxin a.

Authors:  M Marin-Kuan; V Ehrlich; T Delatour; C Cavin; B Schilter
Journal:  J Toxicol       Date:  2011-06-22

Review 7.  Mechanisms of mycotoxin-induced neurotoxicity through oxidative stress-associated pathways.

Authors:  Kunio Doi; Koji Uetsuka
Journal:  Int J Mol Sci       Date:  2011-08-15       Impact factor: 5.923

8.  3',4',5',5,7-pentamethoxyflavone sensitizes Cisplatin-resistant A549 cells to Cisplatin by inhibition of Nrf2 pathway.

Authors:  Xiangyu Hou; Xupeng Bai; Xiaoli Gou; Hang Zeng; Chen Xia; Wei Zhuang; Xinmeng Chen; Zhongxiang Zhao; Min Huang; Jing Jin
Journal:  Mol Cells       Date:  2015-03-31       Impact factor: 5.034

Review 9.  A review of the evidence that ochratoxin A is an Nrf2 inhibitor: implications for nephrotoxicity and renal carcinogenicity.

Authors:  Alice Limonciel; Paul Jennings
Journal:  Toxins (Basel)       Date:  2014-01-20       Impact factor: 4.546

Review 10.  Development of targeted therapy of NRF2high esophageal squamous cell carcinoma.

Authors:  Chorlada Paiboonrungruang; Emily Simpson; Zhaohui Xiong; Caizhi Huang; Jianying Li; Yahui Li; Xiaoxin Chen
Journal:  Cell Signal       Date:  2021-08-04       Impact factor: 4.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.